BIOPORTUGAL QUIMICO FARMACEUTICA, LDA secures contract for 26N00632 - Acquisition Of Reagents Intended For Modulating (Silencing) The Expression Of Genes Of Interest, With The Aim Of Evaluating Their Effect On Cardiac Fibrosis, Through F Analysis Studies

Portugal, March 5 -- Portugal based BIOPORTUGAL QUIMICO FARMACEUTICA, LDA has secured contract from Universidade De Coimbra for 26N00632 - Acquisition Of Reagents Intended For Modulating (Silencing) The Expression Of Genes Of Interest, With The Aim Of Evaluating Their Effect On Cardiac Fibrosis, Through F Analysis Studies. The value of the contract is worth 998800 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....